Literature DB >> 22018231

Native microbiota shape insect vector competence for human pathogens.

Chris M Cirimotich1, Jose L Ramirez, George Dimopoulos.   

Abstract

The resident microbiota of insect vectors can impede transmission of human pathogens. Recent studies have highlighted the capacity of endogenous bacteria to decrease viral and parasitic infections in mosquito and tsetse fly vectors by activating their immune responses or directly inhibiting pathogen development. These microbes may prove effective agents for manipulating the vector competence of malaria and other important human pathogens.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22018231      PMCID: PMC3462649          DOI: 10.1016/j.chom.2011.09.006

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  24 in total

1.  Infectious diseases. Australia to test 'mosquito vaccine' against human disease.

Authors:  Martin Enserink
Journal:  Science       Date:  2010-12-10       Impact factor: 47.728

2.  Natural microbe-mediated refractoriness to Plasmodium infection in Anopheles gambiae.

Authors:  Chris M Cirimotich; Yuemei Dong; April M Clayton; Simone L Sandiford; Jayme A Souza-Neto; Musapa Mulenga; George Dimopoulos
Journal:  Science       Date:  2011-05-13       Impact factor: 47.728

3.  Interactions between La Crosse virus and bacteria isolated from the digestive tract of Aedes albopictus (Diptera: Culicidae).

Authors:  Jonathan D Joyce; Jonathan R Nogueira; Amber A Bales; Kathryn E Pittman; Justin R Anderson
Journal:  J Med Entomol       Date:  2011-03       Impact factor: 2.278

4.  The tsetse fly Glossina fuscipes fuscipes (Diptera: Glossina) harbours a surprising diversity of bacteria other than symbionts.

Authors:  Jenny M Lindh; Michael J Lehane
Journal:  Antonie Van Leeuwenhoek       Date:  2011-01-04       Impact factor: 2.271

5.  A peroxidase/dual oxidase system modulates midgut epithelial immunity in Anopheles gambiae.

Authors:  Sanjeev Kumar; Alvaro Molina-Cruz; Lalita Gupta; Janneth Rodrigues; Carolina Barillas-Mury
Journal:  Science       Date:  2010-03-11       Impact factor: 47.728

Review 6.  Wolbachia and the biological control of mosquito-borne disease.

Authors:  Iñaki Iturbe-Ormaetxe; Thomas Walker; Scott L O' Neill
Journal:  EMBO Rep       Date:  2011-05-06       Impact factor: 8.807

7.  Anopheles gambiae PGRPLC-mediated defense against bacteria modulates infections with malaria parasites.

Authors:  Stephan Meister; Bogos Agianian; Fanny Turlure; Angela Relógio; Isabelle Morlais; Fotis C Kafatos; George K Christophides
Journal:  PLoS Pathog       Date:  2009-08-07       Impact factor: 6.823

Review 8.  Anopheles gambiae innate immunity.

Authors:  Hassan Yassine; Mike A Osta
Journal:  Cell Microbiol       Date:  2009-10-05       Impact factor: 3.715

9.  Implication of the mosquito midgut microbiota in the defense against malaria parasites.

Authors:  Yuemei Dong; Fabio Manfredini; George Dimopoulos
Journal:  PLoS Pathog       Date:  2009-05-08       Impact factor: 6.823

10.  Caspar controls resistance to Plasmodium falciparum in diverse anopheline species.

Authors:  Lindsey S Garver; Yuemei Dong; George Dimopoulos
Journal:  PLoS Pathog       Date:  2009-03-13       Impact factor: 6.823

View more
  120 in total

1.  Dual Insect specific virus infection limits Arbovirus replication in Aedes mosquito cells.

Authors:  Michaela J Schultz; Horacio M Frydman; John H Connor
Journal:  Virology       Date:  2018-04-03       Impact factor: 3.616

Review 2.  Perspectives on the evolutionary ecology of arthropod antimicrobial peptides.

Authors:  Jens Rolff; Paul Schmid-Hempel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

3.  Insect-specific viruses detected in laboratory mosquito colonies and their potential implications for experiments evaluating arbovirus vector competence.

Authors:  Bethany G Bolling; Nikos Vasilakis; Hilda Guzman; Steven G Widen; Thomas G Wood; Vsevolod L Popov; Saravanan Thangamani; Robert B Tesh
Journal:  Am J Trop Med Hyg       Date:  2014-12-15       Impact factor: 2.345

4.  Obligate symbionts activate immune system development in the tsetse fly.

Authors:  Brian L Weiss; Michele Maltz; Serap Aksoy
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

5.  The mosquito microbiota influences vector competence for human pathogens.

Authors:  Nathan J Dennison; Natapong Jupatanakul; George Dimopoulos
Journal:  Curr Opin Insect Sci       Date:  2014-09-01       Impact factor: 5.186

6.  Characterization of a novel insect-specific flavivirus from Brazil: potential for inhibition of infection of arthropod cells with medically important flaviviruses.

Authors:  Joan L Kenney; Owen D Solberg; Stanley A Langevin; Aaron C Brault
Journal:  J Gen Virol       Date:  2014-08-21       Impact factor: 3.891

7.  Ixodes scapularis does not harbor a stable midgut microbiome.

Authors:  Benjamin D Ross; Beth Hayes; Matthew C Radey; Xia Lee; Tanya Josek; Jenna Bjork; David Neitzel; Susan Paskewitz; Seemay Chou; Joseph D Mougous
Journal:  ISME J       Date:  2018-06-26       Impact factor: 10.302

8.  Host response: Microbiota prime antiviral response.

Authors:  Julie K Pfeiffer
Journal:  Nat Microbiol       Date:  2016-01-27       Impact factor: 17.745

9.  Pathogen-mediated manipulation of arthropod microbiota to promote infection.

Authors:  Nabil M Abraham; Lei Liu; Brandon Lyon Jutras; Akhilesh K Yadav; Sukanya Narasimhan; Vissagan Gopalakrishnan; Juliana M Ansari; Kimberly K Jefferson; Felipe Cava; Christine Jacobs-Wagner; Erol Fikrig
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

10.  Gut microbiota of the tick vector Ixodes scapularis modulate colonization of the Lyme disease spirochete.

Authors:  Sukanya Narasimhan; Nallakkandi Rajeevan; Lei Liu; Yang O Zhao; Julia Heisig; Jingyi Pan; Rebecca Eppler-Epstein; Kathleen Deponte; Durland Fish; Erol Fikrig
Journal:  Cell Host Microbe       Date:  2014-01-15       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.